Skip to main content
. Author manuscript; available in PMC: 2021 Oct 13.
Published in final edited form as: Mol Pharm. 2019 Jan 15;16(2):914–920. doi: 10.1021/acs.molpharmaceut.8b01247

Figure 2.

Figure 2.

(a) Inhibition of miR-155 production by different compound (30 μM, 24 h treatment) in HEK293T cells overexpressing miR-155. (b) 1 inhibits endogenous miR-155 formation after 96 h treatment of MCF-7 cells. The error bars represent the standard error of mean (N = 3, *p < 0.05).